| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| LSP 7 Cooperative UA | 14% | $101,078,348 | 5,752,894 | LSP 7 Cooperatieve U.A. | 31 Dec 2024 | |||
| Pivotal bioVenture Partners Fund I, L.P. | 4.9% | $49,946,544 | 2,815,476 | Nan Fung Group Holdings Limited | 30 Sep 2025 | |||
| BVCF IV, L.P. | 5% | $38,510,102 | 2,191,810 | BVCF IV, L.P. | 27 Nov 2024 |
As of 31 Dec 2025, 29 institutional investors reported holding 15,060,123 shares of Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share (OCS). This represents 26% of the company’s total 57,458,694 outstanding shares.
The largest institutional shareholders of Oculis Holding AG - Ordinary Shares, CHF 0.01 par value per share (OCS) together control 26% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 10% | 5,900,294 | 0% | 11% | $117,828,871 |
| Gildi - lifeyrissjodur | 4.3% | 2,447,985 | 0% | 23% | $50,250,171 |
| Pivotal bioVenture Partners Investment Advisor LLC | 4% | 2,288,658 | -0.53% | 18% | $45,704,500 |
| Aberdeen Group plc | 3% | 1,746,946 | +39% | 0.05% | $34,886,512 |
| SR One Capital Management, LP | 1.1% | 641,022 | +99% | 1.8% | $12,801,209 |
| Nan Fung Group Holdings Ltd | 0.9% | 514,702 | 0% | 9.2% | $10,278,599 |
| Alyeska Investment Group, L.P. | 0.58% | 331,332 | +152% | 0.02% | $6,616,700 |
| SYQUANT CAPITAL SAS | 0.34% | 192,722 | 0.47% | $3,849,000 | |
| FOLKETRYGDFONDET | 0.32% | 182,800 | 0.08% | $3,650,516 | |
| Propel Bio Management, LLC | 0.3% | 172,839 | 2.9% | $3,451,595 | |
| NEXTBio Capital Management LP | 0.26% | 149,750 | 0% | 1.8% | $2,990,508 |
| Compagnie Lombard Odier SCmA | 0.19% | 107,300 | +11% | 0.02% | $2,142,781 |
| Simplify Asset Management Inc. | 0.17% | 98,765 | 0.03% | $1,972,337 | |
| ALPS ADVISORS INC | 0.08% | 46,947 | 0.01% | $937,532 | |
| UBS Group AG | 0.08% | 45,916 | -39% | 0% | $916,943 |
| MARSHALL WACE, LLP | 0.08% | 45,773 | 0% | $914,086 | |
| HRT FINANCIAL LP | 0.08% | 43,914 | 0% | $876,000 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.06% | 36,061 | +23% | 0% | $720,138 |
| RENAISSANCE TECHNOLOGIES LLC | 0.04% | 25,000 | 0% | $499,250 | |
| GSA CAPITAL PARTNERS LLP | 0.02% | 13,042 | 0.02% | $260,000 | |
| STATE STREET CORP | 0.02% | 12,519 | +1.1% | 0% | $250,004 |
| Aventura Private Wealth, LLC | 0.01% | 4,000 | 0% | 0.03% | $79,880 |
| BNP PARIBAS FINANCIAL MARKETS | 0.01% | 3,600 | 0% | 0% | $71,892 |
| JPMORGAN CHASE & CO | 0.01% | 3,180 | 0% | $63,505 | |
| MORGAN STANLEY | 0.01% | 3,050 | -52% | 0% | $60,909 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 15,060,123 | $302,113,498 | +$36,161,846 | $19.97 | 29 |
| 2025 Q3 | 10,893,907 | $191,723,678 | -$2,123,823 | $17.58 | 20 |
| 2025 Q2 | 5,105,646 | $99,100,716 | +$2,469,586 | $19.41 | 23 |
| 2025 Q1 | 4,978,440 | $94,739,711 | +$28,331,355 | $19.03 | 20 |
| 2024 Q4 | 3,493,543 | $59,378,651 | +$8,163,517 | $17.00 | 12 |
| 2024 Q3 | 3,013,203 | $36,946,526 | -$3,838,556 | $12.26 | 10 |
| 2024 Q2 | 3,327,448 | $39,763,128 | -$771,604 | $11.95 | 10 |
| 2024 Q1 | 3,392,028 | $40,873,938 | -$7,013,425 | $12.05 | 9 |
| 2023 Q4 | 3,983,142 | $44,273,231 | +$11,534,877 | $11.12 | 7 |
| 2023 Q3 | 2,916,785 | $32,106,736 | -$2,324,387 | $11.00 | 9 |
| 2023 Q2 | 3,125,204 | $38,536,753 | +$147,595 | $12.33 | 9 |
| 2023 Q1 | 3,123,421 | $23,191,122 | +$23,191,122 | $7.43 | 7 |